BRPI0722060A2 - Inibição mediada por shrna de expressão de alfa-1,6-fucosiltransferase - Google Patents
Inibição mediada por shrna de expressão de alfa-1,6-fucosiltransferaseInfo
- Publication number
- BRPI0722060A2 BRPI0722060A2 BRPI0722060-0A2A BRPI0722060A BRPI0722060A2 BR PI0722060 A2 BRPI0722060 A2 BR PI0722060A2 BR PI0722060 A BRPI0722060 A BR PI0722060A BR PI0722060 A2 BRPI0722060 A2 BR PI0722060A2
- Authority
- BR
- Brazil
- Prior art keywords
- fucosiltransferase
- shrna
- alpha
- expression
- mediated inhibition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2869—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/01—Hexosyltransferases (2.4.1)
- C12Y204/01068—Glycoprotein 6-alpha-L-fucosyltransferase (2.4.1.68), i.e. FUT8
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
- C07K2317/41—Glycosylation, sialylation, or fucosylation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
- C12N2310/111—Antisense spanning the whole gene, or a large part of it
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/53—Physical structure partially self-complementary or closed
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06026653 | 2006-12-22 | ||
PCT/EP2007/011160 WO2008077547A1 (en) | 2006-12-22 | 2007-12-19 | Shrna-mediated inhibition of expression of alpha-1. 6-fucosyltransferase |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0722060A2 true BRPI0722060A2 (pt) | 2014-04-01 |
Family
ID=37890199
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0722060-0A2A BRPI0722060A2 (pt) | 2006-12-22 | 2007-12-19 | Inibição mediada por shrna de expressão de alfa-1,6-fucosiltransferase |
Country Status (11)
Country | Link |
---|---|
US (2) | US20100028949A1 (pt) |
EP (1) | EP2097445A1 (pt) |
JP (1) | JP2010512766A (pt) |
KR (1) | KR101114741B1 (pt) |
CN (1) | CN101553503B (pt) |
AU (1) | AU2007338403B2 (pt) |
BR (1) | BRPI0722060A2 (pt) |
CA (1) | CA2672980A1 (pt) |
IL (1) | IL197929A (pt) |
MX (1) | MX2009006336A (pt) |
WO (1) | WO2008077547A1 (pt) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8249332B2 (en) | 2008-05-22 | 2012-08-21 | Matrix Electronic Measuring Properties Llc | Stereoscopic measurement system and method |
US8345953B2 (en) | 2008-05-22 | 2013-01-01 | Matrix Electronic Measuring Properties, Llc | Stereoscopic measurement system and method |
US8326022B2 (en) | 2008-05-22 | 2012-12-04 | Matrix Electronic Measuring Properties, Llc | Stereoscopic measurement system and method |
US9449378B2 (en) | 2008-05-22 | 2016-09-20 | Matrix Electronic Measuring Properties, Llc | System and method for processing stereoscopic vehicle information |
FR2956122A1 (fr) * | 2010-02-08 | 2011-08-12 | Lfb Biotechnologies | Utilisation d'un represseur d'un gene codant une enzyme possedant une activite glycosyltrasferase |
EP3042952A1 (en) | 2015-01-07 | 2016-07-13 | CEVEC Pharmaceuticals GmbH | O-glycan sialylated recombinant glycoproteins and cell lines for producing the same |
US20180238974A1 (en) * | 2017-02-17 | 2018-08-23 | QuSpin Inc. | Gradient Field Optically Pumped Magnetometer |
EP3382014A1 (en) | 2017-03-29 | 2018-10-03 | CEVEC Pharmaceuticals GmbH | Recombinant glycoproteins with reduced antennary fucosylation |
EP3441471A1 (en) * | 2017-08-08 | 2019-02-13 | CEVEC Pharmaceuticals GmbH | Use of constitutively active variants of growth factor receptors as selection makers for the generation of stable producer cell lines |
EP3877408A4 (en) * | 2018-11-06 | 2022-08-24 | University of Miami | COMPOSITIONS AND PRODUCTION OF RECOMBINANT AAV VIRUS VECTORS CAPABLE OF IN VIVO GLYCOENGINEERING |
EP3941480A4 (en) * | 2019-03-18 | 2023-04-26 | Score Pharma, Inc. | FUCOSYLATION INHIBITION COMPOUNDS AND METHODS OF USE THEREOF |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6506559B1 (en) * | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
JPWO2003085118A1 (ja) * | 2002-04-09 | 2005-08-11 | 協和醗酵工業株式会社 | 抗体組成物の製造方法 |
CA2481657A1 (en) * | 2002-04-09 | 2003-10-16 | Kyowa Hakko Kogyo Co., Ltd. | Cells of which genome is modified |
AU2004280065A1 (en) * | 2003-10-09 | 2005-04-21 | Kyowa Hakko Kirin Co., Ltd. | Process for producing antibody composition by using RNA inhibiting the function of alpha1,6-fucosyltransferase |
MX2007015107A (es) * | 2005-06-03 | 2008-02-15 | Genentech Inc | Metodo para producir anticuerpos con funcion mejorada. |
-
2007
- 2007-12-19 AU AU2007338403A patent/AU2007338403B2/en not_active Ceased
- 2007-12-19 MX MX2009006336A patent/MX2009006336A/es not_active Application Discontinuation
- 2007-12-19 KR KR1020097012834A patent/KR101114741B1/ko not_active IP Right Cessation
- 2007-12-19 CN CN2007800426784A patent/CN101553503B/zh not_active Expired - Fee Related
- 2007-12-19 BR BRPI0722060-0A2A patent/BRPI0722060A2/pt not_active IP Right Cessation
- 2007-12-19 EP EP07856883A patent/EP2097445A1/en not_active Withdrawn
- 2007-12-19 WO PCT/EP2007/011160 patent/WO2008077547A1/en active Application Filing
- 2007-12-19 JP JP2009541872A patent/JP2010512766A/ja active Pending
- 2007-12-19 CA CA002672980A patent/CA2672980A1/en not_active Abandoned
- 2007-12-19 US US12/518,128 patent/US20100028949A1/en not_active Abandoned
-
2009
- 2009-04-05 IL IL197929A patent/IL197929A/en not_active IP Right Cessation
-
2010
- 2010-12-01 US US12/957,653 patent/US20110151513A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2097445A1 (en) | 2009-09-09 |
US20110151513A1 (en) | 2011-06-23 |
CN101553503B (zh) | 2012-11-07 |
IL197929A0 (en) | 2011-08-01 |
AU2007338403B2 (en) | 2012-09-06 |
US20100028949A1 (en) | 2010-02-04 |
KR20090106481A (ko) | 2009-10-09 |
AU2007338403A1 (en) | 2008-07-03 |
CN101553503A (zh) | 2009-10-07 |
CA2672980A1 (en) | 2008-07-03 |
KR101114741B1 (ko) | 2012-02-29 |
JP2010512766A (ja) | 2010-04-30 |
IL197929A (en) | 2013-06-27 |
WO2008077547A1 (en) | 2008-07-03 |
MX2009006336A (es) | 2009-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0722060A2 (pt) | Inibição mediada por shrna de expressão de alfa-1,6-fucosiltransferase | |
SMP200900085B (it) | 3-imidazolil-indoli per il trattamento di malattieproliferative. | |
BRPI0807146A2 (pt) | Inibidores da atividade da akt | |
BRPI0718313A2 (pt) | Conjunto de cateter | |
CR10478A (es) | Amino-piperidine derivatives as cetp inhibitors | |
SG10201601846VA (en) | Rnai inhibition of alpha-enac expression | |
BRPI0909422A2 (pt) | conjunto de artigos. | |
DE102006026707A8 (de) | Duschwanne | |
LU93092I2 (de) | Alemtuzumab | |
BRPI0822129A2 (pt) | Inibidores de aldh-2c no tratamento de vício. | |
BR112012003115A2 (pt) | agente de pós-clarificação | |
DE502007004416D1 (de) | Avermectinderivate | |
ITVR20060037A1 (it) | Tovagliolo, particolarmente per sommelier | |
TH99520B (th) | ผ้าอนามัย | |
TH109516B (th) | ผ้าอนามัย | |
TH109515B (th) | ผ้าอนามัย | |
TH102575B (th) | ผ้าอนามัย | |
TH100112B (th) | สุขภัณฑ์ | |
CR10502S (es) | Toalla sanitaria / protector diario | |
TH106829B (th) | สารประกอบตัวยับยั้ง pi3k เบนโซไพแรน และ เบนโซซีพิน และวิธีการของการใช้ | |
ES1063288Y (es) | Dispensador de ceniceros | |
TH93010B (th) | โถส้วม | |
FI20070109L (fi) | WC-istuin-pisuaari-yhdistelmä | |
ITRG20080001U1 (it) | Vassoio - organizer per piatto, bicchiere, posate e tovagliolo usa e getta. | |
ZA200908301B (en) | Rnai inhibition of alpha-enac expression |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2285 DE 21/10/2014. |